Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014

[PR Newswire] – INDIANAPOLIS, April 6, 2014 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies – including bemaciclib beh meh sye’ klib (LY2835219), … more

View todays social media effects on LLY

View the latest stocks trending across Twitter. Click to view dashboard

See who Eli is hiring next, click here to view